WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Ownership - Who owns Nautilus Biotechnology?

Insider buying vs selling

Have Nautilus Biotechnology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sujal M. PatelCEO President and Secretary2024-03-1112,044$2.84
$34.22kBuy
Sujal M. PatelCEO President and Secretary2024-03-082,430$2.99
$7.26kBuy
Sujal M. PatelCEO President and Secretary2024-03-0718,854$2.89
$54.43kBuy
Sujal M. PatelCEO President and Secretary2024-03-069,267$2.70
$25.03kBuy
Sujal M. PatelCEO President and Secretary2024-03-057,405$2.65
$19.59kBuy

1 of 1

NAUT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAUT insiders and whales buy or sell their stock.

NAUT Shareholders

What type of owners hold Nautilus Biotechnology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Parag Mallick16.37%20,479,892$50.59MInsider
Sujal M. Patel15.17%18,973,034$46.86MInsider
Vijay Satyanand Pande14.11%17,653,917$43.61MInsider
Ah Equity Partners Bio Ii LLC14.11%17,653,917$43.61MInsider
Ah Capital Management LLC14.11%17,653,917$43.61MInstitution
Perceptive Advisors LLC10.07%12,594,211$31.11MInstitution
Perceptive Advisors LLC7.28%9,111,151$22.50MInsider
Cercano Management LLC5.73%7,172,985$17.72MInstitution
Matthew S. McIlwain5.18%6,479,845$16.01MInsider
Madrona Venture Group LLC4.81%6,020,770$14.87MInstitution

1 of 3

NAUT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAUT40.64%59.36%Net BuyingNet Buying
PRLD52.43%47.57%Net BuyingNet Selling
ERAS44.64%55.36%Net Buying
LYRA70.88%14.48%Net Buying
AVIR65.45%25.19%Net SellingNet Selling

Nautilus Biotechnology Stock Ownership FAQ

Who owns Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ: NAUT) is owned by 50.70% institutional shareholders, 74.04% Nautilus Biotechnology insiders, and 0.00% retail investors. Parag Mallick is the largest individual Nautilus Biotechnology shareholder, owning 20.48M shares representing 16.37% of the company. Parag Mallick's Nautilus Biotechnology shares are currently valued at $50.38M.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.